Steven L Basta Phathom Pharmaceuticals, Inc. (PHAT) insider trading activity

Steven L Basta is President and CEO of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 364,820 shares of PHAT, which is worth approximately $5.36 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 251,034 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 365K

776.44% 3M change

n/a 12M change

Total Value Held $5.36 Million

Steven L Basta Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	251,034 Added 40.76%	364,820 Common Stock
Dec 17 2025	SELL Payment of exercise price or tax liability	$483,870 $15.36 p/Share	31,502 Reduced 21.68%	113,786 Common Stock
Dec 17 2025	BUY Grant, award, or other acquisition	-	62,038 Added 29.92%	145,288 Common Stock
Nov 28 2025	SELL Payment of exercise price or tax liability	$755,617 $15.62 p/Share	48,375 Reduced 36.75%	83,250 Common Stock
Nov 28 2025	BUY Exercise of conversion of derivative security	-	90,000 Added 40.61%	131,625 Common Stock
Sep 25 2025	SELL Payment of exercise price or tax liability	$564,052 $11.66 p/Share	48,375 Reduced 53.75%	41,625 Common Stock
Sep 25 2025	BUY Exercise of conversion of derivative security	-	90,000 Added 50.0%	90,000 Common Stock

Also insider at

VIVE

VIVEVE MEDICAL, INC. Healthcare

Director

VYNE

VYNE Therapeutics Inc. Healthcare

SLB

Steven L Basta

President and CEO

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAT shares.

Notify only if

Value

Insider Trading

Get notified when an Phathom Pharmaceuticals, Inc. insider buys or sells PHAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Phathom Pharmaceuticals, Inc.

Track Activities on PHAT

Account